» Articles » PMID: 35709447

Spinal Cord Stimulation Alleviates Neuropathic Pain by Attenuating Microglial Activation Via Reducing Colony-Stimulating Factor 1 Levels in the Spinal Cord in a Rat Model of Chronic Constriction Injury

Overview
Journal Anesth Analg
Specialty Anesthesiology
Date 2022 Jun 16
PMID 35709447
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Spinal cord stimulation (SCS) is an emerging, minimally invasive procedure used to treat patients with intractable chronic pain conditions. Although several signaling pathways have been proposed to account for SCS-mediated pain relief, the precise mechanisms remain poorly understood. Recent evidence reveals that injured sensory neuron-derived colony-stimulating factor 1 (CSF1) induces microglial activation in the spinal cord, contributing to the development of neuropathic pain (NP). Here, we tested the hypothesis that SCS relieves pain in a rat model of chronic constriction injury (CCI) by attenuating microglial activation via blocking CSF1 to the spinal cord.

Methods: Sprague-Dawley rats underwent sciatic nerve ligation to induce CCI and were implanted with an epidural SCS lead. SCS was delivered 6 hours per day for 5 days. Some rats received a once-daily intrathecal injection of CSF1 for 3 days during SCS.

Results: Compared with naive rats, CCI rats had a marked decrease in the mechanical withdrawal threshold of the paw, along with increased microglial activation and augmented CSF1 levels in the spinal dorsal horn and dorsal root ganglion, as measured by immunofluorescence or Western blotting. SCS significantly increased the mechanical withdrawal threshold and attenuated microglial activation in the spinal dorsal horn in CCI rats, which were associated with reductions in CSF1 levels in the spinal dorsal horn and dorsal roots but not dorsal root ganglion. Moreover, intrathecal injection of CSF1 completely abolished SCS-induced changes in the mechanical withdrawal threshold and activation of microglia in the spinal dorsal horn in CCI rats.

Conclusions: SCS reduces microglial activation in the spinal cord and alleviates chronic NP, at least in part by inhibiting the release of CSF1 from the dorsal root ganglion ipsilateral to nerve injury.

Citing Articles

Characterization of preclinical models to investigate spinal cord stimulation for neuropathic pain: a systematic review and meta-analysis.

Mugan D, Vuong Q, Dietz B, Obara I Pain Rep. 2025; 10(1):e1228.

PMID: 39816902 PMC: 11732658. DOI: 10.1097/PR9.0000000000001228.


Spinal Cord Stimulation for Spinal Cord Injury-Related Pain: A Pilot Study.

Alamri A, MacDonald M, Al-Mohammad A, Ricciardi L, Hart M, Pereira E Brain Sci. 2025; 14(12.

PMID: 39766372 PMC: 11674956. DOI: 10.3390/brainsci14121173.


Protein arginine methyltransferase-6 regulates heterogeneous nuclear ribonucleoprotein-F expression and is a potential target for the treatment of neuropathic pain.

Zhang X, Liu Y, Xu F, Zhou C, Lu K, Fang B Neural Regen Res. 2024; 20(9):2682-2696.

PMID: 39503430 PMC: 11801299. DOI: 10.4103/NRR.NRR-D-23-01539.


Spinal Cord Stimulation Alleviates Chronic Peripheral Neuropathic Pain Due to Peripheral Nerve Injury: A Case Report.

Nemoto A, Date H Cureus. 2024; 16(9):e69383.

PMID: 39411626 PMC: 11473214. DOI: 10.7759/cureus.69383.


A Narrative Review of the Dorsal Root Ganglia and Spinal Cord Mechanisms of Action of Neuromodulation Therapies in Neuropathic Pain.

da Silva M, Martelossi-Cebinelli G, Yaekashi K, Carvalho T, Borghi S, Casagrande R Brain Sci. 2024; 14(6).

PMID: 38928589 PMC: 11202229. DOI: 10.3390/brainsci14060589.